RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Adrian Franke to 4-Butyrolactone

This is a "connection" page, showing publications Adrian Franke has written about 4-Butyrolactone.
Connection Strength

0.465
  1. Liu G, Li J, Li Y, Hu Y, Franke AA, Liang L, Hu FB, Chan AT, Mukamal KJ, Rimm EB, Sun Q. Gut microbiota-derived metabolites and risk of coronary artery disease: a prospective study among US men and women. Am J Clin Nutr. 2021 07 01; 114(1):238-247.
    View in: PubMed
    Score: 0.199
  2. Sun Q, Wedick NM, Pan A, Townsend MK, Cassidy A, Franke AA, Rimm EB, Hu FB, van Dam RM. Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women. Diabetes Care. 2014; 37(5):1287-95.
    View in: PubMed
    Score: 0.119
  3. Xie J, Tworoger SS, Franke AA, Terry KL, Rice MS, Rosner BA, Willett WC, Hankinson SE, Eliassen AH. Plasma enterolactone and breast cancer risk in the Nurses' Health Study II. Breast Cancer Res Treat. 2013 Jun; 139(3):801-9.
    View in: PubMed
    Score: 0.114
  4. Hu Y, Song Y, Franke AA, Hu FB, van Dam RM, Sun Q. A Prospective Investigation of the Association Between Urinary Excretion of Dietary Lignan Metabolites and Weight Change in US Women. Am J Epidemiol. 2015 Sep 15; 182(6):503-11.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support